The enzyme L-asparaginase was covalently immobilized on the inner surface of the hollow fibers utilized in a commercially available dialyzer by the periodate method. After sterilization with gamma radiation the bioreactor was able to metabolize in vivo, 90 per cent of circulating asparagine in two hours. The absence in blood of asparaginase-related protein fragments, released from the hollow fiber immobilized enzyme, was monitored using a specific enzyme-linked immunosorbent assay (ELISA).
Siu ChongE.D., and ChangT.M.S..: L-Asparaginase as a Model for Enzyme Therapy of Substrate Dependent Tumors. Biomedical Applications of Immobilized Enzymes and Proteins. T.M.S. Chang Ed.Vol.1, 105, 1977.
2.
ChangT.M.S.: Methods for the Therapeutic Applications of Immobilized Enzymes.Meth. Enzymolo.XLIV, 676, 1976.
3.
RossiV., MalinverniA., and CallegaroL..: Immobilization of Arginase on Hollow Fiber.Hemodialyzer. Int. J. Artificial Organs,4, 102, 1981.
4.
CallegaroL., BarbieriU., and DentiE..: Selective Detoxification: Hemoperfusion on Antiphenobarbital Antibodies Immobilized on Solid Phase.Trans. Am. Soc. Artif. Intern. OrgansXXVII, 566, 1981.
5.
HarrisJ.E., WhitecarJ., BodeyG.P., and FreireichE.J..: L-Asparaginase (ASP) in the Treatment of Adult Acute Leukemia.Proc. Am. Cancer Res.,10, 35, 1969.
6.
BerenbaumN.C.: Immunosuppression by L-Asparaginase.Nature,225, 550, 1970.
7.
CooneyD.A., CapizziR.L., and HandschumacherR.E..: Evaluation of L-Asparagine Metabolism in Animals and Man.Cancer Res.30, 929, 1970.
8.
MashburnL.T., and WristonJ.C.Jr..: Tumor Inhibitory Effect of L-Asparaginase.Biochem. Biophys. Res. Commun.,12, 50, 1963.
9.
CallegaroL., and DentiE..: Application of Bioreactors in Medicine. Submitted to: Int. J. Artif Organs.
10.
SteinbuchM., and AudranR..: The Isolation of IgG from Mammalian Sera with the Aid of Caprylic Acid.Arch. Biochem. Biophys.,134, 279, 1969.
11.
NakaneP.K., and KawoiA..: Peroxidase-Labeled Antibody: A New Method of Conjugation.J. Histochem. and Cytochem.,22, 1084, 1974.
12.
DaviesM.E., BarrettA.J., and HembryR.M..: Preparation of Antibody Fragments: Conditions for Proteolysis Compared as SDS Slab Gel Electrophoresis and Quantitation of Antibody Yield.J. Immunol. Methods,21, 305, 1978.
13.
ChangT.M.S.: The in Vivo Effects of Semipermeable Microcapsules Containing L-Asparaginase on 6C3HED Lymphosarcoma.Nature,229, 117, 1971.
14.
KoR.Y.C., and HershL.S..: A Dacron Wool Packed-Bed Extracorporeal Reactor: A Kinetic Study of Immobilized Escherichia Coli II L-Asparaginase.J. Biomed. Mater. Res.,10, 249, 1976.
15.
SampsonD., HershL.S., CooneyD., and MurphyG.P..: A New Technique Employing Extracorporeal Chemotherapy.Trans. Am. Soc. Artif. Intern. Organs, XVIII, 54, 1972.
16.
HeydenH., GelinL.E., LarssonS., and SaarneA..: A New Specific Chemotherapy: A Pilot Study with an Extracorporeal Chamber.Rev. Surg.31, 305, 1974.
17.
HeydenH.: Enzyme Therapy and Immuno-Adsorption by an Extracorporeal Device. Biomater. Med. Devices Artif.Organs,8, 1, 1980.
18.
DumlerF., SinghP., JacksonC.E., KiniK.R., SamhouriA.M., HalcorsohH.R., and ShoreJ.D..: Extracorporeal Enzyme Therapy: Use of an L-Asparaginase Reactor-Dialyzer in a Clinical Setting.Am. Soc. Artif. Intern. Organs,2, 70, 1981.
19.
JacksonJ.A., HalvorsonH.R., FurlongJ.W., LucastK.D., and ShoreJ.D..: A New Extracorporeal Reactor-Dialyzer for Enzyme Therapy Using Immobilized L-Asparaginase.J. Pharm. Exp. Therapeutics,209, 271, 1979.
20.
MazzolaG., and VecchioG..: Immobilization and Characterization of L-Asparaginase on Hollow Fibers.Intern. J. Artif. Organs,3, 120, 1980.
21.
PrattC.B., and JohnsonW.W..: Duration and Severity of Fatty Metamorphosis of the Liver Following L-Asparaginase Therapy.Cancer,28, 361, 1971.
